1120 related articles for article (PubMed ID: 17255880)
1. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
2. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
6. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin therapy for intractable Ménière's disease.
De Beer L; Stokroos R; Kingma H
Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
10. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
Li CS; Lai JT
Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
Smith WK; Sandooram D; Prinsley PR
J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
[TBL] [Abstract][Full Text] [Related]
13. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
Crane BT; Minor LB; Della Santina CC; Carey JP
Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
[TBL] [Abstract][Full Text] [Related]
14. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Ménière's disease.
Schlegel M; Vibert D; Ott SR; Häusler R; Caversaccio MD
Otol Neurotol; 2012 Oct; 33(8):1380-5. PubMed ID: 22931868
[TBL] [Abstract][Full Text] [Related]
15. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease.
Jung J; Chun J; Kim N; Kim Y; Lee WS
Otol Neurotol; 2008 Sep; 29(6):816-23. PubMed ID: 18617871
[TBL] [Abstract][Full Text] [Related]
19. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
20. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
